Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Crisaborole Ointment 2% in Infants and Toddlers With Mild to Moderate Atopic Dermatitis
2019-002836-10Phase 4
- Sponsor
- Pfizer
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of crisaborole in atopic dermatitis (AD), sponsored by Pfizer.
02
Drugs
crisaborole
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2019-002836-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002836-10.